Singapore-based company TauRx Therapeutics has selected BioClinica's Trident IWR/IVR solution to use in a series of expanded Phase III trials for its pipeline of neurology treatment candidates. BioClinica will also be providing Imaging ...
Tags: TauRx, BioClinica, TauRx Therapeutics, neurology treatment